Literature DB >> 23660874

A copula model for marked point processes.

Liqun Diao1, Richard J Cook, Ker-Ai Lee.   

Abstract

Many chronic diseases feature recurring clinically important events. In addition, however, there often exists a random variable which is realized upon the occurrence of each event reflecting the severity of the event, a cost associated with it, or possibly a short term response indicating the effect of a therapeutic intervention. We describe a novel model for a marked point process which incorporates a dependence between continuous marks and the event process through the use of a copula function. The copula formulation ensures that event times can be modeled by any intensity function for point processes, and any multivariate model can be specified for the continuous marks. The relative efficiency of joint versus separate analyses of the event times and the marks is examined through simulation under random censoring. An application to data from a recent trial in transfusion medicine is given for illustration.

Mesh:

Year:  2013        PMID: 23660874     DOI: 10.1007/s10985-013-9259-3

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  12 in total

1.  Testing separability in spatial-temporal marked point processes.

Authors:  Frederic Paik Schoenberg
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

2.  Tests for independence between marks and points of a marked point process.

Authors:  Yongtao Guan
Journal:  Biometrics       Date:  2006-03       Impact factor: 2.571

3.  Likelihood ratio procedures and tests of fit in parametric and semiparametric copula models with censored data.

Authors:  Yildiz E Yilmaz; Jerald F Lawless
Journal:  Lifetime Data Anal       Date:  2011-01-29       Impact factor: 1.588

4.  Semiparametric estimation in copula models for bivariate sequential survival times.

Authors:  Jerald F Lawless; Yildiz E Yilmaz
Journal:  Biom J       Date:  2011-08-24       Impact factor: 2.207

5.  Inferences on the association parameter in copula models for bivariate survival data.

Authors:  J H Shih; T A Louis
Journal:  Biometrics       Date:  1995-12       Impact factor: 2.571

6.  Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study.

Authors:  J Pascual; R M Falk; F Piessens; A Prusinski; P Docekal; M Robert; P Ferrer; X Luria; R Segarra; J M Zayas
Journal:  Cephalalgia       Date:  2000-07       Impact factor: 6.292

7.  A comparison of rabbit antithymocyte serum and OKT3 as prophylaxis against renal allograft rejection.

Authors:  E H Cole; D C Cattran; V T Farewell; M Aprile; R A Bear; Y P Pei; S S Fenton; J A Tober; C J Cardella
Journal:  Transplantation       Date:  1994-01       Impact factor: 4.939

8.  Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study.

Authors:  M Petri; M Genovese; E Engle; M Hochberg
Journal:  Arthritis Rheum       Date:  1991-08

9.  Fluticasone propionate in asthma: a long term dose comparison study.

Authors:  E Verona; D Petrov; E Cserhati; J Hofman; N Geppe; H Medley; S Hughes
Journal:  Arch Dis Child       Date:  2003-06       Impact factor: 3.791

10.  Regular inhaled beta-agonist treatment in bronchial asthma.

Authors:  M R Sears; D R Taylor; C G Print; D C Lake; Q Q Li; E M Flannery; D M Yates; M K Lucas; G P Herbison
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321

View more
  1 in total

1.  This special issue contains several papers on clinical trials, exemplifying Ross Prentice's influence. Preface.

Authors:  Jianwen Cai; Li Hsu
Journal:  Lifetime Data Anal       Date:  2013-10-16       Impact factor: 1.588

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.